QUALITY OF LIFE OF PATIENTS WITH TYPE 1 GAUCHER DISEASE AFTER LONG-TERM ENZYME REPLACEMENT THERAPY
EHA Library, Hongmin Li, 216856
CHANGE OF FIBRINOGEN LEVEL AND ACTIVITY OF FXIII UNDER THE INFLUENCE OF THE REGULATORY PEPTIDES PRO-GLY-PRO AND PRO-GLY-ARG.
EHA Library, Tamara Obergan, 216836
COMBINED ORAL ADMINISTRATION OF ANALGESIA AND ANXIOLYSIS FOR PAIN ASSOCIATED WITH BONE MARROW ASPIRATION AND BIOPSY
EHA Library, Claudio Cerchione, 216878
ACTIONS THAT MAKE ANTICOAGULANT THERAPY SAFER: 10 YEARS ON - DO WE COMPLY? EVALUATING WARFARIN USE AND APPROPRIATENESS AT A LONDON ACUTE HOSPITAL
EHA Library, Drew Harding, 216877
COST OF HEMATOLOGIC CANCERS IN INDIA: A HOSPITAL INPATIENT CARE ANALYSIS
EHA Library, Chepsy Cherian Philip, 216876
PHARMACOECONOMIC EVALUATION OF MANAGEMENT OF DASATINIB AND IMATINIB THERAPY SIDE EFFECTS IN CHRONIC MYELOID LEUKEMIA. MULTICENTRIC RETROSPECTIVE STUDY.
EHA Library, GIULIO GIORDANO, 216875
EVALUATION OF FERRIC MALTOL AS ALTERNATIVE TO PARENTERAL IRON THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN TERMS OF COSTS REDUCTIONS AND HEALTHCARE HUMAN RESOURCE UTILISATION
EHA Library, Silvia Lovato, 216874
THE OTHER SIDE OF THE MOON: PATIENTS’ PERCEPTION OF IMATINIB AND DASATINIB SYMPTOM BURDEN FOR CHRONIC MYELOID LEUKEMIA. RESULTS OF THE PATIENT’S JOURNEY FROM THE REAL-LIFE SOLARIS PROJECT
EHA Library, Fabio Stagno, 216873
STRONG ASSOCIATION BETWEEN HERPES SIMPLEX VIRUS AND CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING INTENSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION
EHA Library, Junshik Hong, 216872
HEALTH-RELATED QUALITY OF LIFE IN CAREGIVER OF HEMOPHILIA PATIENTS
EHA Library, Gonzalo Ferrer Garrido, 216871
KNOWLEDGE, CULTURAL, AND STRUCTURAL BARRIERS TO THALASSEMIA SCREENING IN MIGRANT POPULATIONS IN THAILAND
EHA Library, Julia Xu, 216870
PREVALENCE OF ANXIETY AND DEPRESSION AMONG CAREGIVERS OF CANCER PATIENTS IN MALAYSIA
EHA Library, Kevin Tey Wen Fei, 216869
PROFILE OF "OLDEST OLD" PATIENTS WITH ANEMIA IN A HEMATOLOGY-GERIATRIC INTERDISCIPLINARY CONSULTATION.
EHA Library, Laura Lacalle, 216868
TIME FROM SYMPTOM ONSET TO DIAGNOSIS AND TREATMENT AMONG HEMATOLOGICAL MALIGNANCIES: DISEASE, PATIENT AND HEALTH SYSTEM RELATED INFLUENCING FACTORS
EHA Library, Austėja Dapkevičiūtė, 216867
PREVALENCE OF METABOLIC SYNDROME AND SARCOPENIA AS LONG-TERM LATE EFFECTS IN LYMPHOMA SURVIVORS
EHA Library, Antonella Daniele, 216866
MONTELUKAST AND GEMFIBROZIL IMPROVES SYMPTOM CONTROL AND ENHANCES THE RESPONSE TO ORAL CHEMOTHERAPY IN HAEMATOLOGICAL MALIGNANCIES WITH A POOR PROGNOSIS.
EHA Library, Stephen O'Mara, 216865
RESULTS OF A MULTICENTER UNIVERSAL NEWBORN SCREENING PROGRAM FOR SICKLE CELL DISEASE IN ITALY: A CALL TO ACTION
EHA Library, R Colombatti, 216864
TREATMENT PATTERN AND UNMET NEED IN ADULTS WITH PHILADELPHIA POSITIVE (PH+) RELAPSED OR REFRACTORY (R/R) B-CELL PRECURSOR (BCP) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN EU-5 COUNTRIES.
EHA Library, Xinke Zhang, 216863
TERTIARY PREVENTION FOR PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Pavel Kotoucek, 216862
A REVIEW OF CLINICAL PRACTICE REGARDING DNACPR DECISION MAKING, DISCUSSION AND IMPLEMENTATION
EHA Library, Anneka Burge, 216861
REAL‐WORLD UTILIZATION OF MULTIPLE MYELOMA TREATMENTS IN THE ERA OF NOVEL THERAPIES: WHAT IS THE CURRENT STANDARD OF CARE?
EHA Library, Eric Maiese, 216860
REFERRALS TO HEMATOLOGICAL CONSULTATIONS FOR EOSINOPHILIA – DIFFERENCES BETWEEN GENERAL AND UNIVERSITY HOSPITAL PATIENTS.
EHA Library, Hrvoje Holik, 216859
QUALITATIVE STUDY INVESTIGATING THE PERCEPTIONS OF MYELOPROLIFERATIVE NEOPLASM PATIENTS PARTICIPATING IN AN ONLINE YOGA INTERVENTION
EHA Library, Jennifer Huberty, 216858
INFLUENCE OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR TESTS IN HEALTHY SAUDI BLOOD DONORS
EHA Library, Salwa Bakr, 216857
RITUXIMAB FOR REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENT
EHA Library, Shehab Fareed Abdelgabber, 216837
METABOLIC PROFILE OF CHILDREN AND ADOLESCENTS FOLLOWING TREATMENT FOR HEMATOLOGIC MALIGNANCIES
EHA Library, Despoina Apostolaki, 216855
QUALITY OF LIFE OF TRANSFUSION DEPENDENT THALASSEMIA PATIENTS IN GREECE. A MULTICENTRE STUDY
EHA Library, Philippos Klonizakis, 216854
TEACHING HAEMATOLOGY TO MEDICAL STUDENTS: WHAT DO WE TEACH AND WHAT THEY WANT TO BE TAUGHT
EHA Library, Silvia Lovato, 216853
NEPA (NETUPITANT PLUS PALONOSETRON) FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS RECEIVING STEM CELL TRANSPLANTATION
EHA Library, Mariana Corrochano, 216852
MYELOPROLIFERATIVE NEOPLASMS AND ACCEPTANCE AND COMMITMENT THERAPY: AN ONGOING FEASIBILITY STUDY AIMED AT SYMPTOM MITIGATION AND QUALITY OF LIFE
EHA Library, Leslie Padrnos, 216851
GENERAL HEALTH IN OLDER ADULTS WITH NON-HODGKIN LYMPHOMA USING A COMPREHENSIVE GERIATRIC ASSESSMENT
EHA Library, Daniel Mercante, 216850
THE CHANGE OF QUALITY OF LIFE IN 52 NON-SEVERE APLASTIC ANEMIA PATIENTS AFTER CYCLOSPORINE A THERAPY
EHA Library, Fangfei Chen, 216849
PAIN AND SERIOUS ADVERSE EVENT WITH BONE MARROW ASPIRATION AND BIOPSY: A SINGLE CENTRE EXPERIENCE FROM INDIA
EHA Library, Chepsy Cherian Philip, 216848
GENETIC POLYMORPHISMS AS RISK FACTORS OF ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN
EHA Library, Natalia Korsakova, 216847
PLASMA LEVELS OF SOME HEMOSTATIC MARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES
EHA Library, Yuliya Tyravska, 216846
DEEP VEIN THROMBOSIS IN THE INPATIENT : A TERTIARY CARE ANALYSIS FROM INDIA
EHA Library, Chepsy Cherian Philip, 216845
LEICINE-CONTAINING REGULATORY PEPTIDES PREVENT THE DEVELOPMENT OF TROMBOSIS
EHA Library, Ludmila Lyapina, 216844
THROMBOLYTİC TREATMENT IN A CHILD WITH OF DIFFUSE VENOUS THROMBOSIS: BEHCET'S DISEASE
EHA Library, Sema AYLAN GELEN, 216843
MULTI-ORGAN THROMBOSIS AS A MANIFESTATION OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME IN A CHILD – A CASE REPORT
EHA Library, Sapna Oberoi, 216842
THE ELEVATION OF VON WILLEBRAND FACTOR (VWF) IN THE PATIENTS WITH MALIGNANT LYMPHOMA TREATED WITH RITUXIMAB (R)-CHOP THERAPY
EHA Library, Naomi Shimizu, 216841
ACTIVATION OF PLATELET HAEMOSTASIS AND ITS CORRECTION BY PROLINE-CONTAINING PEPTIDES IN METABOLIC DISORDERS
EHA Library, Marina Grigorjeva, 216840
MAY-THURNER SYNDROME AND RECURRENT DEEP VENOUS THROMBOSIS IN TWO PEDIATRIC CASE TREATED WITH DABIGATRAN ETEXILATE
EHA Library, Selin Aytac, 216839
ANTITHROMBOTIC ACTIVITY OF PEPTIDE SELANK AGAINST THE BACKGROUND OF EXPERIMENTALLY INDUCED ENDOTHELIAL DYSFUNCTION IN RATS
EHA Library, Elina Rogozinskaya, 216838
EHA23 Educational Updates in Hematology
EHA Library, EHA annual congress, 219399
EHA23 Abstract Book
EHA Library, EHA annual congress, 219320
TLS risk assessment with CLL therapies
EHA Library, John Gribben, 209967
TLS prophylaxis and monitoring
EHA Library, John Seymour, 209966
Clinical management of TLS
EHA Library, Barbara Eichhorst, 209965
A challenging course through a difficult landscape
EHA Library, Delivered by Janssen, 205759
HME FORUM Optimizing Outcomes For Patients With CLL
EHA Library, Delivered by Janssen, 202871
HME FORUM The Clinical Implications of Our Improved Understanding Of CLL Biology
EHA Library, Delivered by Janssen, 202872
Emerging treatment goals in chronic myeloid lymphoma
EHA Library, Delivered by Novartis, 202870
Registration form for mentors
EHA Library, Course Faculty, 196305
Treatment of Patients With Myelofibrosis and Uncontrolled Polycythemia Vera
EHA Library, Delivered by Novartis, 193789
ITP and AA: Our current understanding and what the future might hold
EHA Library, Delivered by Novartis, 192923
From biology to targeted therapies in chronic lymphocytic leukemia
EHA Library, Stephan Stilgenbauer, 184561
Hemophilia Treatment: Navigating Speed Bumps on the Innovation Highway
EHA Library, Donna DiMichele, 184560
INDUCTION OF HEMOGENIC REPROGRAMMING IN HUMAN FIBROBLASTS
EHA Library, Andreia Gomes, 183930
Managing CLL patients after BCR inhibitor failure
EHA Library, Jeffrey Jones, 184553
Harnessing T cells for Immunotherapy of AML
EHA Library, Marion Subklewe, 184556
New Treatment Approaches In Myeloma In 2017
EHA Library, Jesús San Miguel, 184549
Treatment Of Aggressive Lymphoma Focused On Elderly Patients
EHA Library, Michael Pfreundschuh, 184545
New drugs for old? What is the role of B-cell receptor pathway inhibition in the front line therapy of CLL in 2017?
EHA Library, Stephen Devereux, 184552
CRYPTIC INSERTIONS OF IMMUNOGLOBULIN LIGHT CHAIN ENHANCER REGIONS ACTIVATE CCND3 AND CCND2 IN CYCLIN D1-NEGATIVE MANTLE CELL LYMPHOMAS
EHA Library, Silvia Bea, 183929
Role of enhancers in the pathogenesis of AML
EHA Library, Ruud Delwel, 184555
First-line therapy for CLL in 2017
EHA Library, Alessandra Tedeschi, 184551
Genetic Classification Of Myeloma For Prognostication And Treatment Selection
EHA Library, Hervé Avet-Loiseau, 184548
Relapsed aggressive lymphoma: Can we optimize the therapy
EHA Library, Gilles Salles, 184544
BONE MARROW SITES DIFFERENTLY IMPRINT DORMANCY AND CHEMORESISTANCE TO T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Francoise Pflumio, 183931
ANTI-CD69 MAB TREATMENT INCREASES THE CAPACITY OF NK CELLS TO ELIMINATE HYPER-REACTIVE ALLOGENIC T CELLS AND PREVENTS ACUTE GRAFT VERSUS HOST DISEASE
EHA Library, Katerina Tsilingiri, 183933
Iron Chelation in Hemoglobinopathies 
EHA Library, Vip Viprakasit, 192910
ARNT/HIF-1BETA LINKS POOR CLINICAL OUTCOME TO MICROENVIRONMENTAL HYPOXIA AND HIGH-RISK 1Q GAIN IN MULTIPLE MYELOMA
EHA Library, Fengyan Jin, 183932
Immunopathology of MM
EHA Library, Nikhil Munshi, 184547
The Biological Basis Of Aggressive Lymphoma
EHA Library, Elias Campo, 184543
GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS
EHA Library, Gilles Salles, 183934
GvL / GvHD
EHA Library, Fred Falkenburg, 192908
Indications For Transplantation In MDS
EHA Library, Matteo Giovanni Della Porta, 184533
Prioritisation Therapies In CLL
EHA Library, Clemens Wendtner, 184524
Red Cell Transfusion: When To Transfuse In Patients With Hematological Malignancies?
EHA Library, Miquel Lozano, 184537
Heat Shock Protein 70 (HSP70), one of the major key factors in Diamond-Blackfan anemia
EHA Library, Lydie Da Costa, 184541
Pregnancy during and after treatment. Myths and reality.
EHA Library, Jane APPERLEY, 192902
ELN-EHA-SWG on CML
EHA Library, Jerry Radich, 184529
Immune microenvironment in the pathogenesis of MDS
EHA Library, Shahram Kordasti, 184532
ELN-EHA-SWG on CML
EHA Library, Daniela Krause, 184528
Prognostic Factors In CLL: When, Which And How?
EHA Library, Sarka Pospisilova, 184523
Challenges In Typing And Matching Strategies In Patients With Hematological Maligancies In The Era Of Immunotherapy
EHA Library, Karen Vooght, 184536
Iron overload before, during and after bone marrow transplantation
EHA Library, Emanuele Angelucci, 184539
ELN-EHA-SWG on CML
EHA Library, Alois Gratwohl, 184527
Clonal Evolution In MDS
EHA Library, Joop Jansen, 184531
ELN-EHA-SWG on CML
EHA Library, Delphine Rea, 184526
Relevance Of Microenvironment In CLL
EHA Library, Federico Caligaris-Cappio, 184522
Transferrin and TfR1 in co-regulation of erythropoiesis and iron metabolism
EHA Library, Yelena Ginzburg, 184540
Cell-derived Microvesicles And Microparticles In Blood Components: Consequences For Transfusion Recipients
EHA Library, Thierry Burnouf, 184535
T-CELL RECEPTOR Β (TRB) REPERTOIRE CHARACTERISTICS IN RELAPSED/REFRACTORY (R/R) B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL) ON BLINATUMOMAB TREATMENT.
EHA Library, Henrik Knecht, 182090
ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH DELETION 5Q OR MONOSOMY 5: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY (ALWP) OF THE EBMT
EHA Library, Xavier Poiré, 182085
A PHASE 1B STUDY OF THE COMBINATION OF VADASTUXIMAB TALIRINE AND 7+3 INDUCTION THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Moshe Y. Levy, 182080
POOLED SURVIVAL ANALYSIS OF MIDOSTAURIN CLINICAL STUDY DATA (D2201 + A2213) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM) COMPARED WITH HISTORICAL CONTROLS
EHA Library, Andreas Reiter, 182075
PEMBROLIZUMAB PLUS LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY AND BIOMARKER RESULTS FROM THE PHASE 1 KEYNOTE-023 STUDY
EHA Library, Paula Rodríguez-Otero, 182070
13-YR FOLLOW UP OF MULTICENTER RANDOMIZED CHOP-R VS R-HDS TRIAL IN HIGH RISK FOLLICULAR LYMPHOMA PATIENTS: PROLONGED SURVIVAL AND HIGH RATE OF LONG-TERM DISEASE FREE SURVIVORS
EHA Library, Corrado Tarella, 182065
THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES COMPLETE INHIBITION OF SYK AND JAK AND RAPID TUMOR RESPONSES IN A PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES
EHA Library, Paul Hamlin, 182060

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings